- Home
- CGEM vs AMSF Comparison
CGEM vs AMSF Comparison
Compare CGEM & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- AMSF
- Stock Information
- Founded
- CGEM 2016
- AMSF 1985
- Country
- CGEM United States
- AMSF United States
- Employees
- CGEM N/A
- AMSF N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- AMSF Accident &Health Insurance
- Sector
- CGEM Health Care
- AMSF Finance
- Exchange
- CGEM Nasdaq
- AMSF Nasdaq
- Market Cap
- CGEM 530.0M
- AMSF 869.6M
- IPO Year
- CGEM 2021
- AMSF 2005
- Fundamental
- Price
- CGEM $7.60
- AMSF $45.41
- Analyst Decision
- CGEM Strong Buy
- AMSF Buy
- Analyst Count
- CGEM 6
- AMSF 2
- Target Price
- CGEM $28.17
- AMSF $59.50
- AVG Volume (30 Days)
- CGEM 348.1K
- AMSF 137.0K
- Earning Date
- CGEM 08-07-2025
- AMSF 07-24-2025
- Dividend Yield
- CGEM N/A
- AMSF 9.99%
- EPS Growth
- CGEM N/A
- AMSF N/A
- EPS
- CGEM N/A
- AMSF 2.48
- Revenue
- CGEM N/A
- AMSF $301,216,000.00
- Revenue This Year
- CGEM N/A
- AMSF $1.43
- Revenue Next Year
- CGEM N/A
- AMSF $5.54
- P/E Ratio
- CGEM N/A
- AMSF $18.41
- Revenue Growth
- CGEM N/A
- AMSF N/A
- 52 Week Low
- CGEM $6.85
- AMSF $42.48
- 52 Week High
- CGEM $21.01
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- CGEM 49.62
- AMSF 60.40
- Support Level
- CGEM $7.29
- AMSF $44.26
- Resistance Level
- CGEM $7.96
- AMSF $44.96
- Average True Range (ATR)
- CGEM 0.37
- AMSF 0.80
- MACD
- CGEM 0.03
- AMSF 0.37
- Stochastic Oscillator
- CGEM 65.03
- AMSF 100.00
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums.